REPRODUCTIVE HEALTH ​OBSERVATORY (INDIA)
  • ABOUT US
  • Maternal Health
  • ABORTION
  • FAMILY PLANNING
  • OTHER RH ISSUES
  • Events

Biocon Breast Cancer Drug too Expensive, say Health Activists

1/28/2014

0 Comments

 
Biocon’s launch of the world’s first bio-similar of Trastuzumab, a critical breast cancer drug, is unlikely to benefit patients in a big way if the company sticks to the prices it has indicated, claimed health activists on Monday.  They allege that Roche, which retails the drug at . 75,000 for 440 mg vial, sells it at a discount to its long-term patients through many of its dealers for . 55,000-57,000. Biocon’s retail price of . 56,000 per 440 mg vial doesn’t make the drug much cheaper. 

Source: The Times of India 
Read more 
0 Comments



Leave a Reply.

    Back >>>

    News on Other Repro Health 
    This is a collection of news clippings from differnt newspapers on other reproductive health issues 

    Archives

    February 2014
    January 2014
    December 2013
    November 2013
    September 2013
    August 2013
    June 2013
    October 2012

    Categories

    All
    Health Service Delivery
    Reproductive Choices And Rights

    RSS Feed

Picture
Maternal Health
Picture
Family Planning
Picture
Abortion
Picture
Other Reproductive Health Issues
easily put counter
Website Traffic
 Developed and designed by Centre for Health and Social Justice (c) 2013
  • ABOUT US
  • Maternal Health
  • ABORTION
  • FAMILY PLANNING
  • OTHER RH ISSUES
  • Events